Clinical Trial Update: Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder? [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports results on whether Risperidone Consta reduces relapse and rehospitalization in bipolar disorder, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Risperidone Consta (risperidone)

Snippet

Sponsor: Vanderbilt University | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-07-31